The OptionELITE inferior vena cava filter protects against recurrent pulmonary embolism (PE). It can be retrieved or remain implanted depending on whether the patient needs short-term or long-term PE protection. With over six years of positive, consistent and proven clinical performance, the OptionELITE filter has a unique anchoring system that makes retrievals easier. The OptionELITE is cleared for delivery using a standard or over-the-wire technique via jugular, femoral, antecubital, or popliteal access.

vailable with a 100cm Delivery Sheath for Popliteal Access

• The only IVC filter indicated for popliteal access
• Increases efficiency in DVT treatment procedures by eliminating the need for patient repositioning after placement
• Smallest delivery system available with a 5F ID delivery sheath, enabling more access options
• Over six years of positive, consistent and proven clinical performance with very low risk of complications

Over-The-Wire Delivery

By delivering the OptionELITE over-the-wire, the filter is given a path to follow for a predictable and accurate placement. The additional control provided by the guidewire:

• Stabilizes the filter’s apex during deployment
• Places the apex in the center of the IVC
• Positions the filter for easier retrieval

Delivery System Attributes

• A low-profile 5F ID delivery system to reduce trauma at the access site
• A curved pusher to aid centering and resist tilt during deployment
• A universal cartridge for femoral/popliteal or jugular/antecubital delivery
• Available with a 70cm delivery sheath for delivery via jugular and femoral access or 100cm delivery sheath for delivery via antecubital and popliteal access

Indications

The OptionELITE Inferior Vena Cava Filter is intended for the prevention of recurrent PE via placement in the vena cava in the following conditions:

• Pulmonary thromboembolism when anticoagulant therapy is contraindicated
• Failure of anticoagulation therapy in thromboembolic diseases
• Emergency treatment following massive PE when anticipated benefits of conventional therapy are reduced
• Chronic, recurrent PE when anticoagulation therapy has failed or is contraindicated